Pluristyx, powered by panCELLa, is an advanced therapy tools and services company whose primary mission is to help companies and researchers solve raw material and manufacturing challenges in the field of drug development, regenerative medicine, and cell and gene therapy. Pluristyx provides seamless end-to-end client support by offering clinical-grade mRNA-reprogrammed and genetically-edited induced pluripotent stem cells (iPSCs), best-in-class FailSafe and iACT Stealth Cells platform edits, and GMP contract development and manufacturing services to significantly trim the time needed to transition from the bench to the bedside. Pluristyx also offers groups the opportunity to decouple the hassles of iPSC expansion and banking from differentiation and product development through its proprietary Ready-To-Differentiate (RTD™) format that be directly employed for drug product manufacturing. Pluristyx, powered by the panCELLa platform, effectively allows early-stage companies to focus precious resources on therapeutic application rather than manufacturing hurdles, with the ultimate goal of advancing promising laboratory discoveries into patients.

Pluristyx logo



Event details

Date: November 6 - 8, 2023

Event contact

Patrick Barry
Area Director
Europe: Automotive and Life Sciences


21 in total